Insights

Strategic partnerships AskBio is a Bayer subsidiary with ongoing collaborations and partnerships across gene therapy, neuromuscular diseases, and Belief Biomed BBM, presenting opportunities to align with contract development and manufacturing, distribution, and co-development discussions.

Clinical momentum Active clinical development including PROGRESS-GT LOPD in Phase 1/2 and durable gene therapy programs suggest demand for specialized manufacturing, regulatory support, and patient access solutions as programs progress.

Manufacturing expansion Recent facility expansion in the Triangle region and joint ventures with Austrianova to scale cell-based production indicate readiness for contract manufacturing, process development, and tech transfer partnerships.

Technology stack Use of BNP delivery platform and a modern tech stack (Kubernetes, PostgreSQL, cloud identity, collaboration tools) highlights potential needs for CRO/CMO data integration, secure collaboration, and scalable data infrastructure to support trials.

Funding and scale signals Revenue under one million and growth-oriented milestones, plus strategic investments from pharma partners, signal a buyer with expansion budgets and appetite for bundled services around development, manufacturing, and regulatory affairs.

Similar companies to Asklepios BioPharmaceutical Inc

Asklepios BioPharmaceutical Inc Tech Stack

Asklepios BioPharmaceutical Inc uses 8 technology products and services including Tableau, Lucidchart, Kubernetes, and more. Explore Asklepios BioPharmaceutical Inc's tech stack below.

Media & News

Asklepios BioPharmaceutical Inc's Email Address Formats

Asklepios BioPharmaceutical Inc uses at least 3 email formats:
Asklepios BioPharmaceutical Inc Email FormatsExamplePercentage
FLast@askbio.comJDoe@askbio.com
95%
First.Last@askbio.comJohn.Doe@askbio.com
3%
FMiddleLast@askbio.comJMichaelDoe@askbio.com
2%

Frequently Asked Questions

What is Asklepios BioPharmaceutical Inc's phone number?

Minus sign iconPlus sign icon
You can contact Asklepios BioPharmaceutical Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Asklepios BioPharmaceutical Inc's official website and social media links?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical Inc's official website is askbio.com and has social profiles on LinkedIn.

How much revenue does Asklepios BioPharmaceutical Inc generate?

Minus sign iconPlus sign icon
As of July 2026, Asklepios BioPharmaceutical Inc's annual revenue is estimated to be <$1M.

What is Asklepios BioPharmaceutical Inc's SIC code and NAICS code?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical Inc's SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Asklepios BioPharmaceutical Inc have currently?

Minus sign iconPlus sign icon
As of July 2026, Asklepios BioPharmaceutical Inc has approximately 1 employees across 2 continents, including North America and Europe. Key team members include Chief Patent Officer: C. S. and Vice President, Communications: R. F. Explore Asklepios BioPharmaceutical Inc's employee directory with LeadIQ.

What industry does Asklepios BioPharmaceutical Inc belong to?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical Inc operates in the Biotechnology industry.

What technology does Asklepios BioPharmaceutical Inc use?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical Inc's tech stack includes Tableau, Lucidchart, Kubernetes, PostgreSQL, Azure Active Directory, Microsoft Active Directory, SAP Concur and Atlassian Confluence.

What is Asklepios BioPharmaceutical Inc's email format?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical Inc's email format typically follows the pattern of FLast@askbio.com. Find more Asklepios BioPharmaceutical Inc email formats with LeadIQ.
Asklepios BioPharmaceutical Inc logo

Asklepios BioPharmaceutical Inc

BiotechnologyNorth Carolina, United States0-1 Employees

Asklepios BioPharmaceutical Inc., known as AskBio, is a privately held biotechnology company focused on developing protein and cellular therapies through its Biological Nano Particles (BNP) platform. The BNP technology aims to enable sustained, systemic delivery of therapeutic proteins by using the patient's own cells as bioreactors and pumps to produce and release the treatment. Founded in 2003 and based in Chapel Hill, North Carolina, the company operates as a small, clinical-stage enterprise. Its programs target neuromuscular and other indications, including AB-1009 for late-onset Pompe disease in a Phase 1/2 trial (PROGRESS-GT LOPD). In May 2026, the company dosed the first participant in this trial, reflecting progress in its clinical validation.

Section iconCompany Overview

Phone number
Website
askbio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
0-1

Section iconFunding & Financials

  • <$1M

    Asklepios BioPharmaceutical Inc's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.